Gilead Sciences, Inc business logo
Medicine Questions
Report an Adverse Event
Investors
Contact
Global Operations
North America
  • Canada
  • Mexico
  • USA
South America
  • Argentina
  • Brazil
Asia
  • China Mainland
  • Hong Kong
  • India
  • Japan
  • Korea
  • Singapore
  • Taiwan
Middle East
  • Israel
  • Saudi Arabia
  • Türkiye
  • United Arab Emirates
Africa
  • South Africa
Australia
  • Australia and New Zealand
Europe
  • Austria
  • Belgium and Luxembourg
  • Czech Republic & Slovakia
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Iceland
  • Ireland
  • Italy
  • Netherlands
  • Norway
  • Poland & The Baltics
  • Portugal
  • Romania
  • Russia
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom
Gilead Logo
  • Our Company
    About Us Leadership U.S. Public Policy Engagement Policies and Disclosures Supplier Information U.S. Locations
  • Our Purpose
    Partnerships and Community Corporate Giving Gilead Foundation Inclusion and Diversity Environmental, Social, Governance (ESG) Sustainability Advancing Global Health Medication Access
  • Science & Medicine
    Our Therapeutic Areas Medicines Pipeline Research Clinical Trials
  • News and Press
    Events Stories Newsroom Company Statements Annual Reports
  • Careers
    Careers at Gilead Our Culture Meet Our Employees Inclusion and Diversity in Hiring Compensation, Benefits and Wellbeing Our Global Footprint Early Career Opportunities Postdoctoral Fellowships Hiring Events Talent Community Sign-up
  • Utility
    Privacy Statements Terms Of Use Social Media Guidelines Sitemap
BACK TO MAIN MENU Leadership Governance and Committees
BACK TO MAIN MENU U.S. Public Policy Engagement Political Contributions Archives
BACK TO MAIN MENU Policies and Disclosures Policies Disclosures
BACK TO MAIN MENU Supplier Information Supplier Enablement Resources Supplier Inclusion
BACK TO MAIN MENU Partnerships and Community COMPASS Initiative HepConnect HIV Age Positively Toward Health Equity for Black People Impacted by TNBC Toward Health Equity Oncology Grant RADIAN TRANScend
BACK TO MAIN MENU Corporate Giving What We Fund Funding Requests Zeroing In: Ending the HIV Epidemic Zeroing In: Latin America & The Caribbean (LAC) Region
BACK TO MAIN MENU Gilead Foundation Creating Possible Fund
BACK TO MAIN MENU Environmental, Social, Governance (ESG) Reporting U.N. Global Compact U.N. Sustainable Development Goals
BACK TO MAIN MENU Sustainability Our Business Is Sustainable Performance
BACK TO MAIN MENU Advancing Global Health COVID-19 HCV Elimination
BACK TO MAIN MENU Medication Access U.S. Patient Access Global Access Authorized Distributors
BACK TO MAIN MENU Our Therapeutic Areas Virology Oncology Inflammation
BACK TO MAIN MENU Research Research Scholars Program Compassionate Use Investigator-Sponsored Research
BACK TO MAIN MENU Newsroom Press Releases Media Inquiries
BACK TO MAIN MENU Early Career Opportunities Internship Program
BACK TO MAIN MENU Privacy Statements Cookie Statement Global Applicant Privacy Statement Healthcare Professional Privacy Notice - U.S. only
BACK TO MAIN MENU
North America
  • Canada
  • Mexico
  • USA
South America
  • Argentina
  • Brazil
Asia
  • China Mainland
  • Hong Kong
  • India
  • Japan
  • Korea
  • Singapore
  • Taiwan
Middle East
  • Israel
  • Saudi Arabia
  • Türkiye
  • United Arab Emirates
Africa
  • South Africa
Australia
  • Australia and New Zealand
Europe
  • Austria
  • Belgium and Luxembourg
  • Czech Republic & Slovakia
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Iceland
  • Ireland
  • Italy
  • Netherlands
  • Norway
  • Poland & The Baltics
  • Portugal
  • Romania
  • Russia
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom
BACK TO MAIN MENU

Contact

  • Request Medicines Information
  • Report an Adverse Event
  • Partnership Request
  • Medicine Questions
  • Report an Adverse Event
  • Investors
  • Contact
  • Global Operations
Toggle Inner Dropdown
BACK TO MAIN MENU Google.com
  • Events
  • Stories
  • Newsroom
    • Press Releases
    • Media Inquiries
  • Company Statements
  • Annual Reports

Newsroom

A Cut Above the Rest: Innovative Barbershop Program Educates Indigenous Men About HIV

The Gilead-funded program is changing the dialogue around HIV, one haircut at a time.

Stories@Gilead - July 20, 2023

photo of men getting their haircut.

Recent Story Posts

photo of men getting their haircut.
Access and Health Equity

A Cut Above the Rest: Innovative Barbershop Program Educates Indigenous Men About HIV

Stories@Gilead - July 20, 2023 - 2 min read

People and Culture

Putting a spotlight on the Mental Health Needs of LGBTQ+ Youth

Stories@Gilead - June 29, 2023 - 5 min read

photo of Joel Silver and his triplet daughters
People and Culture

Balancing Legal Work at Gilead and Family Life with Triplets: Joel’s Story

Stories@Gilead - June 13, 2023 - 4 min read

Recent Press Releases

  • July 23, 2023

    New Biktarvy® Data Presented at IAS 2023 Further Demonstrate Safety and Efficacy Profile in a Broad Range of People and Communities Affected by the Global HIV Epidemic
  • July 23, 2023

    Gilead Sciences Announces Its Largest Commitment to Health Equity for Australian and Canadian Indigenous Communities

Explore More

View Upcoming Events

Company Statements

2021 Year in Review

Twitter
 

For more information, contact us.

Phone:
1-800-GILEAD-5 (1-800-445-3235) 1-800-GILEAD-5 (1-800-445-3235)

Email:
public_affairs@gilead.com

Gilead Sciences, Inc business logo

© 1996-2023 Gilead Sciences, Inc. All rights reserved.

AREAS OF INTEREST

  • Careers
  • Environmental, Social, Governance (ESG)
  • Medicines
  • Partnerships and Community
  • Pipeline
  • Stories@Gilead

INFORMATION

  • Contact Us
  • Investor Calls
  • Press Room
  • Report an Adverse Event
  • Sitemap

LEGAL

  • Cookie Statement
  • Modern Slavery Act Statement
  • Privacy Statement
  • Public Policy Engagement
  • Social Media Guidelines
  • Terms of Use

FOLLOW US

  • twitter
  • linkedin
  • Instagram
  • facebook
  • youtube

Headline

Intersititial body copy

Ok Cancel